Topics

FDA clears Biofourmis’ RhythmAnalytics for AI-based interpretation of cardiac arrhythmias

14:38 EDT 1 May 2019 | Compelo Medical Devices

It uses an enhanced deep-learning technique to detect over 15 types of cardiac arrhythmias along with beat-by-beat morphology computation which include ventricular arrhythmias, ventricular ectopic beats and all

The post FDA clears Biofourmis’ RhythmAnalytics for AI-based interpretation of cardiac arrhythmias appeared first on Compelo Medical Devices - Latest industry news and analysis.

Original Article: FDA clears Biofourmis’ RhythmAnalytics for AI-based interpretation of cardiac arrhythmias

NEXT ARTICLE

More From BioPortfolio on "FDA clears Biofourmis’ RhythmAnalytics for AI-based interpretation of cardiac arrhythmias"

Quick Search